Neurocrine Biosciences Stock Price History

Below is the normalized historical share price chart for Neurocrine Biosciences extending back to May 23, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurocrine Biosciences stands at 128.91, as last reported on the 4th of August, with the highest price reaching 129.09 and the lowest price hitting 124.54 during the day. If you're considering investing in Neurocrine Stock, it is important to understand the factors that can impact its price. At this stage we consider Neurocrine Stock to be very steady. Neurocrine Biosciences has Sharpe Ratio of 0.0885, which conveys that the firm had a 0.0885 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Neurocrine Biosciences, which you can use to evaluate the volatility of the firm. Please verify Neurocrine Biosciences' Downside Deviation of 1.9, mean deviation of 1.25, and Risk Adjusted Performance of 0.1289 to check out if the risk estimate we provide is consistent with the expected return of 0.14%. At this time, Neurocrine Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.9 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 63.6 M in 2025. . At this time, Neurocrine Biosciences' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 6.06 in 2025, whereas Price To Sales Ratio is likely to drop 5.53 in 2025. Neurocrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0885

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	NBIX	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return